Clinical Trials Update: Highlights of the Scientific Sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP Trial and HARDBALL

Overview

Journal Eur J Heart Fail

Publisher Wiley

Specialty Cardiology & Vascular Diseases

Date 2002 May 30

PMID 12034166

Citations 6

Authors

Alison Coletta

Simon Thackray

Nikolay Nikitin

John G F Cleland

Affiliations

Soon will be listed here.

Abstract

This article continues a series of reports updating recent research developments of particular interest to personnel involved in the treatment and management of patients with heart failure. This is a summary of selected presentations made at the American College of Cardiology 51st Annual Scientific Session held in Atlanta on 17-20 March 2002. Reports of the following clinical studies are included: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.

Citing Articles

Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling.

Lehmann L, Rostosky J, Buss S, Kreusser M, Krebs J, Mier W Proc Natl Acad Sci U S A. 2014; 111(37):13499-504.

PMID: 25197047 PMC: 4169911. DOI: 10.1073/pnas.1409026111.

Causes and treatment of oedema in patients with heart failure.

Clark A, Cleland J Nat Rev Cardiol. 2013; 10(3):156-70.

PMID: 23319101 DOI: 10.1038/nrcardio.2012.191.

Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.

Leslie S, Spratt J, McKee S, Strachan F, Newby D, Northridge D Heart. 2005; 91(7):914-9.

PMID: 15958361 PMC: 1768985. DOI: 10.1136/hrt.2004.040386.

Autonomic changes in patients with heart failure and in post-myocardial infarction patients.

Frenneaux M Heart. 2004; 90(11):1248-55.

PMID: 15486114 PMC: 1768543. DOI: 10.1136/hrt.2003.026146.

Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide.

Leslie S, Rahman M, Denvir M, Newby D, Webb D Br J Clin Pharmacol. 2004; 57(6):720-5.

PMID: 15151517 PMC: 1884515. DOI: 10.1111/j.1365-2125.2004.02074.x.